TG and type 2 diabetes mellitus: 10-weeks randomized double-blind placebo-controlled trial in 44 T2D patients:- hs-CRP decrease (-2.5 ± 4.3 mg/L)- Tg–lowering (-14.2 ± 30.6 mg/dl)